Evolent Health, Inc Class A Common Stock (EVH)

Price$4.22

Value ScoreB

Growth ScoreC

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-7.45%

Price vs S&P 500 (4W)0.97%

VGM Score56.74

Market Capitalization$474.67M

All Metrics

P/CF (Annual)12.22x

Book Value / Share (Quarterly)$3.52

P/TBV (Annual)2.56x

Revenue Growth (3Y)11.54%

Cash Flow / Share (Quarterly)$0.01

Price vs S&P 500 (YTD)-2.66%

Gross Margin (TTM)20.18%

Net Profit Margin (TTM)-26.29%

EPS (TTM)$-4.44

10-Day Avg Trading Volume2.45M

EPS Excl Extra (TTM)$-4.44

Revenue Growth (5Y)15.20%

EPS (Annual)$-4.68

ROI (Annual)-38.57%

Gross Margin (Annual)21.31%

Net Profit Margin (5Y Avg)-8.44%

Cash / Share (Quarterly)$1.26

Revenue Growth QoQ (YoY)2.60%

ROA (Last FY)-28.14%

Revenue Growth TTM (YoY)-21.26%

EBITD / Share (TTM)$-2.86

ROE (5Y Avg)-30.13%

Operating Margin (TTM)-23.17%

Cash Flow / Share (Annual)$0.04

P/B Ratio1.20x

P/B Ratio (Quarterly)0.64x

Net Income / Employee (Annual)$-127,300

EV / Revenue (TTM)0.69x

Net Interest Coverage (TTM)-4.07x

ROA (TTM)-22.85%

EV / EBITDA (TTM)20.08x

EPS Incl Extra (Annual)$-4.68

Current Ratio (Annual)1.31x

Quick Ratio (Quarterly)1.26x

3-Month Avg Trading Volume3.02M

52-Week Price Return-48.47%

EV / Free Cash Flow (Annual)274.69x

Revenue / Employee (TTM)$449,700

Tangible BV / Share (Quarterly)$1.96

P/S Ratio (Annual)0.25x

Asset Turnover (Annual)0.99x

52-Week High$12.06

Operating Margin (5Y Avg)-6.31%

EPS Excl Extra (Annual)$-4.68

CapEx CAGR (5Y)1.42%

Tangible BV CAGR (5Y)-3.59%

26-Week Price Return0.48%

Quick Ratio (Annual)1.27x

13-Week Price Return24.12%

Total Debt / Equity (Annual)2.34x

Current Ratio (Quarterly)1.32x

Enterprise Value$1.31B

Revenue / Share Growth (5Y)8.57%

Asset Turnover (TTM)0.87x

Book Value / Share Growth (5Y)-12.72%

Revenue / Employee (Annual)$446,700

Pretax Margin (Annual)-28.50%

Cash / Share (Annual)$1.36

3-Month Return Std Dev84.88%

Gross Margin (5Y Avg)22.03%

Net Income / Employee (TTM)$-118,200

EBITDA Interim CAGR (5Y)27.91%

ROE (Last FY)-128.74%

Net Interest Coverage (Annual)-7.31x

EPS Basic Excl Extra (Annual)$-4.68

P/FCF (TTM)9.91x

Receivables Turnover (TTM)5.07x

EV / Free Cash Flow (TTM)936.29x

Total Debt / Equity (Quarterly)2.46x

EPS Incl Extra (TTM)$-4.44

Receivables Turnover (Annual)5.18x

ROI (TTM)-30.08%

P/S Ratio (TTM)0.25x

Pretax Margin (5Y Avg)-9.83%

Revenue / Share (Annual)$16.43

Tangible BV / Share (Annual)$4.44

Forward P/E24.30x

Price vs S&P 500 (52W)-72.84%

Year-to-Date Return5.50%

5-Day Price Return1.20%

EPS Normalized (Annual)$-4.68

ROA (5Y Avg)-7.70%

Net Profit Margin (Annual)-28.49%

Month-to-Date Return6.84%

Cash Flow / Share (TTM)$0.01

EBITD / Share (Annual)$-2.74

Operating Margin (Annual)-22.84%

LT Debt / Equity (Annual)2.34x

P/CF (TTM)14.26x

ROI (5Y Avg)-10.73%

LT Debt / Equity (Quarterly)2.46x

EPS Basic Excl Extra (TTM)$-4.44

P/TBV (Quarterly)4.32x

P/B Ratio (Annual)1.08x

Pretax Margin (TTM)-26.32%

Book Value / Share (Annual)$3.72

Price vs S&P 500 (13W)15.86%

Beta0.77x

P/FCF (Annual)99.83x

Revenue / Share (TTM)$16.88

ROE (TTM)-71.48%

52-Week Low$2.10

vGradeB

gGradeC

mGradeC

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-0.02est. -0.05

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.20

4.15

Industry Peers — Management Services(4)

Symbol	Value Score	Growth Score	Momentum Score	Price
EVHEvolent Health, Inc Class A Common Stock	B	C	C	$4.22
RTORentokil Initial plc American Depositary Shares (each representing five (5) Ordinary Shares)	D	B	B	$29.70
ITGartner, Inc.	C	C	D	$164.02
FCFranklin Covey Company	C	D	B	$23.93
TDICDreamland Limited Class A Ordinary Shares	—	F	F	$0.22

About

Evolent Health provides technology and services that enable health systems, physician organizations, and health plans to transition to value-based care models. The company delivers specialty care management across oncology, cardiology, and musculoskeletal markets, along with integrated total cost of care management and health plan administration solutions.